How Big Pharma Suppresses ‘Biosimilars’
Biologic drugs—pharmaceuticals produced from living organisms—are at the forefront of medical innovation and hold tremendous potential to improve and save lives. Unfortunately, their pricing has been a driver of rapidly escalating, unsustainable drug costs. Congress recognized the need for …
Marian MC Chrvala flipped this story into INSIGHTS INTO CANCER•1760d